Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Andrulis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The HER-2/neu oncogene in breast cancer: so what is new?M N Levine, I Andrulis
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 25, 1999
Molecular alterations in bone and soft-tissue sarcomaR S Bell, J Wunder, I Andrulis
Archives of Pathology & Laboratory Medicine|January 1, 1992
Expression and amplification of neu oncogene in pleomorphic adenomas of salivary glandH J Kahn, W Hanna, M Auger, et al.
Journal of the National Cancer Institute|April 20, 1994
Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacementA Sekyi-Otu, R Bell, I Andrulis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 1990
Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseasesW Hanna, H J Kahn, I Andrulis, et al.
Carcinogenesis|August 30, 2000
Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimensJ C Rice, H Ozcelik, P Maxeiner, et al.
American Journal of Clinical Pathology|April 11, 2001
Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistryF P O'Malley, R Parkes, E Latta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
British Journal of Cancer|November 17, 2004
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsA S Whittemore, R R Balise, P D P Pharoah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcomaE de Alava, A Kawai, J H Healey, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The HER-2/neu oncogene in breast cancer: so what is new?M N Levine, I Andrulis
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 25, 1999
Molecular alterations in bone and soft-tissue sarcomaR S Bell, J Wunder, I Andrulis
Archives of Pathology & Laboratory Medicine|January 1, 1992
Expression and amplification of neu oncogene in pleomorphic adenomas of salivary glandH J Kahn, W Hanna, M Auger, et al.
Journal of the National Cancer Institute|April 20, 1994
Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacementA Sekyi-Otu, R Bell, I Andrulis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 1990
Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseasesW Hanna, H J Kahn, I Andrulis, et al.
Carcinogenesis|August 30, 2000
Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimensJ C Rice, H Ozcelik, P Maxeiner, et al.
American Journal of Clinical Pathology|April 11, 2001
Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistryF P O'Malley, R Parkes, E Latta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
British Journal of Cancer|November 17, 2004
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsA S Whittemore, R R Balise, P D P Pharoah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcomaE de Alava, A Kawai, J H Healey, et al.
Pageof 2